Drug safety is an essential factor that has to be under control in every medical institution. In case of inaccurate accounting procedures, the local medical personnel might be responsible for the loss of a particular item. The following paper will discuss and cover a strategy of applying a drug safety approach in the field of nursing and its impact on advanced professional practices.
specifically for you
for only $16.05 $11/page
To keep precise records of all medicaments that providers deliver to a particular hospital, nurse practitioners are obliged to register all of the new items in a special accounting journal (Reich et al., 2015). Another important drug safety measure implies the usage of prepared and disinfected storage cells (Adams & Urban, 2015). Usually, it is a room that has certain temperature settings because liquid medicines require additional standards to remain in safe keeping conditions (Karch, 2017).
The effect of the strategy discussed above on advanced nursing practice is evident (Cadogan, Ryan, & Hughes, 2015). When a patient needs drugs to reduce his or her pain or to keep one’s blood pressure stable, a required medicament will be ready for its usage. (Gagne, Wang, Rassen, & Schneeweiss, 2014). Moreover, drugs cannot be accessed by people who do not work in a hospital and do not have medical education (Davies et al., 2016). Their application by non-professionals is illegal and might cause harm to one’s body and health in particular.
Drugs need to be preserved in accordance with all the necessary standards to make their usage beneficial for patients and inaccessible to people who do not have appropriate legal rights. This factor has a significant impact on nursing practice, as it requires additional attention and accounting. In case of disregarding drug safety standards, patients’ health conditions might worsen, whereas a nurse practitioner may be legally responsible for the situation that has emerged.
Adams, M., & Urban, C. Q. (2015). Pharmacology: Connections to nursing practice. Boston, MA: Pearson.
Cadogan, C. A., Ryan, C., & Hughes, C. M. (2015). Appropriate polypharmacy and medicine safety: When many is not too many. Drug Safety, 39(2), 109-116. Web.
Davies, M. R., Wang, K., Mirams, G. R., Caruso, A., Noble, D., Walz, A.,… Polonchuk, L. (2016). Recent developments in using mechanistic cardiac modelling for drug safety evaluation. Drug Discovery Today, 21(6), 924-938. Web.
100% original paper
on any topic
done in as little as
Gagne, J. J., Wang, S. V., Rassen, J. A., & Schneeweiss, S. (2014). A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment. Pharmacoepidemiology and Drug Safety, 23(6), 619-627. Web.
Karch, A. M. (2017). Focus on nursing pharmacology. Philadelphia, PA: Wolters Kluwer.
Reich, K., Mrowietz, U., Radtke, M. A., Thaci, D., Rustenbach, S. J., Spehr, C., & Augustin, M. (2015). Drug safety of systemic treatments for psoriasis: Results from the German psoriasis registry PsoBest. Archives of Dermatological Research, 307(10), 875-883. Web.